Measles spreads through the air. When an infected person coughs, sneezes, or even breathes, tiny virus-laden droplets and aerosol particles float in the surrounding space, and anyone who inhales them or touches a contaminated surface and then touches their mouth or nose can become infected. What makes measles extraordinary among infectious diseases is how efficiently it does this: a single infected person in a fully susceptible population would, on average, infect 12 to 18 others, a figure that dwarfs most other common viruses. That combination of airborne persistence and extreme contagiousness is why measles remains one of the most transmissible human diseases ever documented, and why even small dips in vaccination coverage can spark outbreaks.
Airborne Transmission and How Long the Virus Lingers
Measles is caused by the measles virus (MeV), a member of the paramyxovirus family. It travels primarily as an aerosol, meaning the viral particles are small enough to remain suspended in the air for extended periods rather than dropping to the ground quickly. A systematic review of experimental and real-world studies found that measles virus can survive in the air for roughly 30 minutes to two hours after an infected person leaves a room, depending on conditions.1PubMed Central. A systematic review to guide measles exposure periods for contact tracing That means you do not even need to be in the same room as an infected person at the same time to catch it. Walking through a space where someone with measles stood an hour earlier can be enough.
Humidity plays a major role in how long the virus remains infectious. In dry conditions with relative humidity around 12 to 15 percent, the virus survived up to two hours in laboratory experiments. At moderate humidity (around 36 to 37 percent), survival dropped to about 60 minutes, and at high humidity (60 to 70 percent), it lasted around 30 minutes.2medRxiv. A Systematic Review of Measles Virus Transmisability in the Air to Guide Exposure Periods for Contact Tracing in Public Spaces This pattern is consistent with modeling work showing that measles infection risk decreases as indoor relative humidity rises, and that even increasing ventilation does not eliminate the humidity effect as thoroughly as it does for some other airborne viruses.3Scientific Reports. Modeling the impact of indoor relative humidity on the infection risk of five respiratory airborne viruses In practical terms, measles thrives in dry, poorly ventilated indoor spaces. Waiting rooms, airplanes, school classrooms, and shopping centers in winter are ideal environments for the virus to persist long enough to reach a new host.
Why Measles Is So Much More Contagious Than Other Viruses
The standard measure of how contagious an infectious disease is, the basic reproduction number or R0, describes how many people one infected person would infect in a population where nobody is immune. For measles, this number is often cited as 12 to 18.4PubMed. The basic reproduction number (R(0)) of measles: a systematic review To put that in perspective, seasonal influenza has an R0 in the range of 1 to 2, and the original strain of SARS-CoV-2 was estimated around 2 to 3. Measles is in a league of its own among common human pathogens.
Several biological features explain that number. First, the virus is genuinely airborne, not just spread by large droplets that fall within a meter or two. Those tiny aerosol particles drift and circulate, especially in enclosed spaces. Second, people with measles start shedding virus about four days before the rash appears, so they are spreading it before they know they are sick. Third, the virus is remarkably efficient at entering human cells. It initially targets immune cells in the respiratory tract by binding to a specific receptor, then later spreads to epithelial cells throughout the body using a second receptor called nectin-4.5PLoS Pathogens. Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus This two-receptor strategy gives the virus a way to establish infection deep in the lungs and then amplify itself across the airway lining, flooding the respiratory tract with new virus particles that are easily exhaled into the environment.
The Timeline of Infection
Understanding the timeline of measles helps explain both how it spreads and when it becomes dangerous. After you inhale the virus, there is an incubation period of roughly 10 to 14 days before symptoms appear. The first symptoms look like a bad cold: high fever, cough, runny nose, and red, watery eyes. Small white spots called Koplik’s spots sometimes appear inside the cheeks and are considered a distinctive early sign, though they are easy to miss.
The famous rash typically shows up about three to five days after the fever begins, starting on the face and spreading downward to the trunk and limbs. Research has traced the rash to a specific sequence of events: infected immune cells traveling through the bloodstream seed the virus into the skin, where it infects resident immune cells in the dermis. From there, infection spreads outward to keratinocytes in the epidermis. When the body’s immune system eventually fights back, the resulting inflammation causes the redness and swelling that produce the characteristic blotchy rash.6PLOS Pathogens. Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis
Crucially, a person with measles is contagious from about four days before the rash appears until about four days after it appears. That pre-rash contagious window is a major reason measles spreads so effectively: during those early days, most people just think they have a cold and go about their normal lives, exposing others in schools, offices, and public transit.
Immune Amnesia and the Hidden Damage
Measles does not just cause a rash and fever. One of the most concerning discoveries about the virus in recent years is that it can wipe out a large chunk of your existing immune memory, a phenomenon researchers call “immune amnesia.” The virus preferentially infects and destroys memory B cells, the immune cells responsible for remembering past infections and vaccinations. A study using immune-cell sequencing before and after measles infection found two distinct consequences: the body’s pool of naive B cells was reconstituted incompletely, leaving the immune system in a more immature state, and previously expanded memory B cell populations were depleted, compromising the body’s ability to fight off pathogens it had already encountered.7PubMed. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles
In plain terms, recovering from measles can erase years of immune protection built up through previous infections and vaccinations. This immunosuppression persists well after the clinical illness resolves, which is why populations that experience measles outbreaks tend to see increases in other infectious diseases for months or even years afterward. It is one of the reasons measles kills: not always from the virus itself, but from the secondary infections it leaves the body unable to fight.
Serious Complications
For many healthy, well-nourished people in high-income countries, measles is a miserable but survivable illness. But complications are far more common than people tend to assume. Roughly one in four people who get measles in the United States will be hospitalized. Pneumonia, either from the virus itself or from secondary bacterial infection, is the most common cause of measles-related death. Encephalitis, or swelling of the brain, occurs in about one out of every thousand cases and can cause permanent brain damage.
The rarest and most devastating complication is subacute sclerosing panencephalitis, or SSPE, a chronic brain disease that can develop years after the initial measles infection. SSPE causes progressive inflammation and destruction of brain tissue and is almost always fatal.8PubMed Central. Subacute Sclerosing Panencephalitis: Impact on Public Health, Current Insights, and Future Perspectives It occurs most often in people who had measles very young, particularly before the age of two. SSPE is extremely rare, but there is no treatment, which makes preventing measles infection in the first place especially important for infants and toddlers.
Vitamin A and Why Nutrition Matters
Vitamin A deficiency is a recognized risk factor for severe measles, and this connection is one of the reasons measles remains a major killer of children in low-income countries. Deficiency worsens the illness and increases the likelihood of dangerous complications including corneal damage and blindness.9Emerging Infectious Diseases. Severe Measles, Vitamin A Deficiency, and the Roma Community in Europe Making matters worse, measles itself depletes the body’s vitamin A stores, creating a vicious cycle in children who were already borderline deficient. The World Health Organization recommends vitamin A supplementation for all children diagnosed with measles, and Cochrane review evidence supports this practice as a way to reduce complications.10PubMed Central. Vitamin A for treating measles in children Even in high-income countries, vitamin A supplementation is part of standard measles treatment in children.
Who Is Most Vulnerable
Infants are at particularly high risk because they are too young to be vaccinated (the first dose of measles vaccine is given at 12 to 15 months in most countries) and depend on maternal antibodies for protection. However, those maternal antibodies wane quickly. In settings where measles has been eliminated and mothers were vaccinated rather than naturally infected, infants lose protective antibody levels even earlier. A systematic review found that in measles-elimination settings, some infants become susceptible well before the age of routine immunization.11PubMed. Waning of measles maternal antibody in infants in measles elimination settings – A systematic literature review A study in Laos measured antibody levels at various scheduled vaccination time points and found that by the time infants reached the recommended age for their first measles vaccine dose, only about 14 percent still had protective antibody levels.12PubMed Central. Waning of Maternal Antibodies against Measles Suggests a Large Window of Susceptibility in Infants in Lao People’s Democratic Republic
Pregnant women and people with weakened immune systems are also at heightened risk, both for severe measles and because they cannot receive the live vaccine. Their protection depends entirely on the people around them being vaccinated, which is the practical heart of the herd immunity concept.
What to Do After Exposure
If you have been exposed to someone with measles and you are not immune, there are two main options for post-exposure prophylaxis, and the clock is tight. The measles-mumps-rubella vaccine, given within 72 hours of exposure, can prevent infection or significantly reduce its severity in people six months of age and older who have no contraindications.13PubMed Central. Updated NACI recommendations for measles post-exposure prophylaxis For infants younger than six months, pregnant women, and immunocompromised individuals who cannot receive a live vaccine, immunoglobulin given within six days of exposure is the standard approach.
A systematic review of post-exposure prophylaxis found that immunoglobulin reduced measles infection rates to 0 to 30 percent among recipients, while vaccine-based prophylaxis brought rates down to 0 to 15 percent, with effectiveness estimates for both approaches ranging widely but often exceeding 80 percent.14PubMed. Post-exposure prophylaxis for the prevention of measles: A systematic review A Cochrane review confirmed that immunoglobulins given within seven days of exposure substantially cut the risk of developing measles.15Cochrane Database of Systematic Reviews. Immunoglobulins for preventing measles The takeaway is that timing matters enormously. If you suspect you have been exposed and you are not sure of your vaccination status, contacting a healthcare provider the same day is not an overreaction.
Why the Vaccine Still Works After Decades
One question people reasonably ask is whether measles could mutate its way around the vaccine the way influenza or SARS-CoV-2 have done. The answer, at least so far, is that this is extremely unlikely. After decades of global vaccination, no measles genotype has emerged that can escape vaccine-induced immunity. Research has shown this is because the virus’s surface proteins have multiple overlapping antigenic sites that the immune system targets simultaneously. To evade antibodies, the virus would need to change many of these sites at once, but those same sites are also essential for the virus to bind to its human receptors. Mutating them enough to escape immune recognition would likely break the virus’s ability to infect cells in the first place.16PubMed Central. Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins
Cross-neutralization testing across different measles genotypes has shown that vaccine-induced antibodies work against all of them, with variation of less than about six-fold between genotypes.17PubMed Central. Evaluation of Measles Vaccine Immunogenicity and Durability Using A Pseudotyped Virus Neutralization Assay In functional terms, the vaccine from the 1960s still protects against every known strain circulating today. The immunity from a successful primary vaccination series persists for at least 15 years and likely much longer, with evidence suggesting that the second dose acts more as a catch-up for the small percentage of people who did not respond fully to the first dose rather than as a true booster.18PubMed Central. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China That said, some research has noted that specific markers of measles immunity may wane at different rates over time, and neutralizing antibody levels measured 17 years after vaccination were fairly low in one cohort, highlighting gaps in understanding about what constitutes protective immunity over a lifetime.19PubMed Central. Differential durability of immune responses to measles and mumps following MMR vaccination
Why Measles Keeps Coming Back
Given that an effective, stable, affordable vaccine has existed for over 50 years, you might wonder why measles is making a comeback. Multiple intersecting forces are responsible. Vaccine hesitancy fueled by misinformation, reduced vaccine uptake during and after the COVID-19 pandemic, and a general loss of awareness about how serious measles can be have all contributed to pockets of under-vaccination in communities around the world.20PubMed Central. A Review of the Resurgence of Measles, a Vaccine-Preventable Disease, as Current Concerns Contrast with Past Hopes for Measles Elimination
Because of measles’ extremely high R0, herd immunity requires roughly 92 to 95 percent of a population to be immune. Even modest drops in coverage below that threshold open the door to outbreaks. In the United States in 2025, more than 90 percent of confirmed cases occurred in people who were unvaccinated or whose vaccination status was unknown, and nearly all cases were linked to undervaccinated communities. Air travel quickly distributed the virus from initial clusters in Texas, New Mexico, and Oklahoma to additional states, illustrating how a single imported case can ignite widespread transmission when local protection is uneven.21PubMed Central. The 2025 United States Measles Crisis: When Vaccine Hesitancy Meets Reality
Globally, the picture is shaped by economics and conflict as much as by vaccine attitudes. Analysis of 192 countries between 2018 and 2023 found that armed conflict significantly increased measles incidence, while higher coverage with a second vaccine dose reduced it. Regions with lower GDP per capita bore a disproportionate burden, reflecting weaker health infrastructure and more limited access to routine vaccination.22PubMed Central. Spatial-temporal pattern and drivers associated with measles resurgence from 2018 to 2023: a global perspective from 192 countries In wealthy countries, vaccine refusal tends to cluster among middle- to high-income families where parents prefer social media narratives over physician-based information, have low perceived disease risk, and are skeptical of vaccine safety.23PubMed Central. Why Parents Say No to Having Their Children Vaccinated against Measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy In lower-income countries, the barrier is more often lack of access rather than active refusal.
How Measles Became a Human Disease
Measles is an exclusively human virus. No animal reservoir exists, which is part of why elimination through vaccination is theoretically possible. But this was not always the case. Measles virus evolved from rinderpest virus, a closely related pathogen that infected cattle and was successfully eradicated in 2011. Molecular clock analysis of a 1912 measles virus genome suggests that the two viruses diverged potentially as early as the sixth century BCE, roughly coinciding with the emergence of large, densely populated cities in the ancient world.24PubMed Central. Measles virus and rinderpest virus divergence dated to the sixth century BCE Dense populations were likely necessary for the virus to sustain human-to-human transmission chains, since measles burns through susceptible populations quickly and needs a steady supply of new hosts. This is still true: without a critical mass of unvaccinated people in contact with each other, an outbreak fizzles out.
Before vaccines existed, measles swept through populations in regular epidemic cycles. Swiss records from the early twentieth century show incidence peaks roughly every three years, with most deaths concentrated among children under five.25American Journal of Epidemiology. Reconstructing the spread of measles in the 20th century: an epidemiological analysis of the period prior to the introduction of vaccination in Switzerland When measles reached previously isolated populations, the results could be catastrophic: mortality rates during some early twentieth-century epidemics among islanders and camp internees climbed as high as 40 percent, driven largely by secondary bacterial pneumonias and gastrointestinal complications.26American Journal of Epidemiology. Measles Epidemics of Variable Lethality in the Early 20th Century These historical patterns underscore an important point: measles severity is not fixed. It depends heavily on the population’s nutritional status, prior exposure to other respiratory pathogens, crowding, and access to medical care.
Diagnosing Measles in a Low-Incidence World
One underappreciated problem in places where measles has been rare for decades is that many physicians have never seen a case. The rash can be confused with other viral illnesses, drug reactions, or even rubella. Laboratory confirmation is essential, and the standard approach has evolved from older methods like virus isolation in cell culture to blood tests that detect measles-specific antibodies and molecular techniques such as real-time RT-PCR, which can identify viral genetic material directly from throat swabs or urine samples.27PubMed Central. Diagnostic Approaches for Measles Virus: Methods, Advances, and Ongoing Challenges
Rapid diagnostic tests are being developed for use in the field, but their performance is still a work in progress. A study evaluating a measles IgM rapid test in Malaysia found that sensitivity using capillary blood was only about 43 percent, meaning it missed more than half of true cases, though specificity was high at 98 percent.28PubMed Central. A measles IgM rapid diagnostic test to address challenges with national measles surveillance and response in Malaysia In an outbreak setting, a negative rapid test does not reliably rule out measles, which has practical implications for how quickly exposed individuals are isolated and how aggressively public health authorities pursue contact tracing. For now, laboratory-based testing remains the gold standard, and delays in getting results can mean days during which an undiagnosed case is still spreading the virus.